These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22961748)

  • 41. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
    Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
    Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible detection of pancreatic cancer by plasma protein profiling.
    Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; Kikuchi S; Endo M; Tsuchida A; Aoki T; Itoi T; Moriyasu F; Hirohashi S; Yamada T
    Cancer Res; 2005 Nov; 65(22):10613-22. PubMed ID: 16288055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu T; Xue R; Huang X; Zhang D; Dong L; Wu H; Shen X
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):542-50. PubMed ID: 21659380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C; Pan C; Shen J; Wang H; Yong L
    Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
    Zhao L; Liu Y; Sun X; Peng K; Ding Y
    J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
    Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
    J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.
    Xu Y; Xu Q; Yang L; Ye X; Liu F; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
    Clin Cancer Res; 2013 Jun; 19(11):3039-49. PubMed ID: 23536436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
    Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
    J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting.
    Zhu D; Zhong Y; Wu H; Ye L; Wang J; Li Y; Wei Y; Ren L; Xu B; Xu J; Qin X
    J Surg Res; 2013 Oct; 184(2):861-6. PubMed ID: 23721930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
    Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
    Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
    J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts.
    Wang H; Luo C; Zhu S; Fang H; Gao Q; Ge S; Qu H; Ma Q; Ren H; Wang Y; Wang W
    Oncotarget; 2017 Aug; 8(35):59376-59386. PubMed ID: 28938643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative mass spectrometry for colorectal cancer proteomics.
    Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
    Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.
    Karczmarski J; Rubel T; Mikula M; Wolski J; Rutkowski A; Zagorowicz E; Dadlez M; Ostrowski J
    Acta Biochim Pol; 2013; 60(3):417-25. PubMed ID: 24046818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.